FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981724301> ?p ?o ?g. }

• W1981724301 endingPage "1372" @default.
• W1981724301 startingPage "1366" @default.
• W1981724301 abstract "The cytokine interleukin (IL)-1 mediates ischaemic brain damage in rodents. The endogenous, highly selective, IL-1 receptor antagonist (IL-1ra) protects against ischaemic cerebral injury in a range of experimental settings, and IL-1ra causes a marked reduction of cell death when administered peripherally or at a delay in transient cerebral ischaemia. We report here the first randomised, double blind, placebo controlled trial of recombinant human IL-1ra (rhIL-1ra) in patients with acute stroke.Patients within 6 hours of the onset of symptoms of acute stroke were randomised to rhIL-1ra or matching placebo. Test treatment was administered intravenously by a 100 mg loading dose over 60 seconds, followed by a 2 mg/kg/h infusion over 72 h. Adverse events and serious adverse events were recorded for up to 3 months, serial blood samples were collected for biological markers up to 3 months, and 5-7 day brain infarct volume was measured by computed tomography.No adverse events were attributed to study treatment among 34 patients randomised. Markers of biological activity, including neutrophil and total white cell counts, C reactive protein, and IL-6 concentrations, were lower in rhIL-1ra treated patients. Among patients with cortical infarcts, clinical outcomes at 3 months in the rhIL-1ra treated group were better than in placebo treated.These data suggest that rhIL-1ra is safe and well tolerated in acute stroke. In addition, rhIL-1ra exhibited biological activity that is relevant to the pathophysiology and clinical outcome of ischaemic stroke. Our findings identify rhIL-1ra as a potential new therapeutic agent for acute stroke." @default.
• W1981724301 created "2016-06-24" @default.
• W1981724301 creator A5001134449 @default.
• W1981724301 creator A5029502706 @default.
• W1981724301 creator A5056679042 @default.
• W1981724301 creator A5074936791 @default.
• W1981724301 creator A5083311472 @default.
• W1981724301 creator A5083544354 @default.
• W1981724301 creator A5083931903 @default.
• W1981724301 date "2005-10-01" @default.
• W1981724301 modified "2023-09-30" @default.
• W1981724301 title "A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients" @default.
• W1981724301 cites W1969532917 @default.
• W1981724301 cites W1969661146 @default.
• W1981724301 cites W1980213283 @default.
• W1981724301 cites W2013118579 @default.
• W1981724301 cites W2017201352 @default.
• W1981724301 cites W2017312269 @default.
• W1981724301 cites W2017812906 @default.
• W1981724301 cites W2017966545 @default.
• W1981724301 cites W2027123157 @default.
• W1981724301 cites W2045839175 @default.
• W1981724301 cites W2049927826 @default.
• W1981724301 cites W2053216945 @default.
• W1981724301 cites W2056034889 @default.
• W1981724301 cites W2056765412 @default.
• W1981724301 cites W2057979643 @default.
• W1981724301 cites W2070614971 @default.
• W1981724301 cites W2074229539 @default.
• W1981724301 cites W2074571664 @default.
• W1981724301 cites W2078103827 @default.
• W1981724301 cites W2085752173 @default.
• W1981724301 cites W2088318869 @default.
• W1981724301 cites W2102355378 @default.
• W1981724301 cites W2102754585 @default.
• W1981724301 cites W2110571889 @default.
• W1981724301 cites W2123358937 @default.
• W1981724301 cites W2131799206 @default.
• W1981724301 cites W2134088303 @default.
• W1981724301 cites W2141580911 @default.
• W1981724301 cites W2142820305 @default.
• W1981724301 cites W2159515166 @default.
• W1981724301 cites W2292308933 @default.
• W1981724301 cites W2414367703 @default.
• W1981724301 cites W2169742106 @default.
• W1981724301 cites W2265085808 @default.
• W1981724301 doi "https://doi.org/10.1136/jnnp.2004.054882" @default.
• W1981724301 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1739363" @default.
• W1981724301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16170078" @default.
• W1981724301 hasPublicationYear "2005" @default.
• W1981724301 type Work @default.
• W1981724301 sameAs 1981724301 @default.
• W1981724301 citedByCount "382" @default.
• W1981724301 countsByYear W19817243012012 @default.
• W1981724301 countsByYear W19817243012013 @default.
• W1981724301 countsByYear W19817243012014 @default.
• W1981724301 countsByYear W19817243012015 @default.
• W1981724301 countsByYear W19817243012016 @default.
• W1981724301 countsByYear W19817243012017 @default.
• W1981724301 countsByYear W19817243012018 @default.
• W1981724301 countsByYear W19817243012019 @default.
• W1981724301 countsByYear W19817243012020 @default.
• W1981724301 countsByYear W19817243012021 @default.
• W1981724301 countsByYear W19817243012022 @default.
• W1981724301 countsByYear W19817243012023 @default.
• W1981724301 crossrefType "journal-article" @default.
• W1981724301 hasAuthorship W1981724301A5001134449 @default.
• W1981724301 hasAuthorship W1981724301A5029502706 @default.
• W1981724301 hasAuthorship W1981724301A5056679042 @default.
• W1981724301 hasAuthorship W1981724301A5074936791 @default.
• W1981724301 hasAuthorship W1981724301A5083311472 @default.
• W1981724301 hasAuthorship W1981724301A5083544354 @default.
• W1981724301 hasAuthorship W1981724301A5083931903 @default.
• W1981724301 hasBestOaLocation W19817243011 @default.
• W1981724301 hasConcept C11988809 @default.
• W1981724301 hasConcept C126322002 @default.
• W1981724301 hasConcept C127413603 @default.
• W1981724301 hasConcept C142724271 @default.
• W1981724301 hasConcept C149892131 @default.
• W1981724301 hasConcept C170493617 @default.
• W1981724301 hasConcept C197934379 @default.
• W1981724301 hasConcept C204787440 @default.
• W1981724301 hasConcept C27081682 @default.
• W1981724301 hasConcept C2776885963 @default.
• W1981724301 hasConcept C2778122271 @default.
• W1981724301 hasConcept C2778690821 @default.
• W1981724301 hasConcept C2780645631 @default.
• W1981724301 hasConcept C42219234 @default.
• W1981724301 hasConcept C535046627 @default.
• W1981724301 hasConcept C71924100 @default.
• W1981724301 hasConcept C78519656 @default.
• W1981724301 hasConceptScore W1981724301C11988809 @default.
• W1981724301 hasConceptScore W1981724301C126322002 @default.
• W1981724301 hasConceptScore W1981724301C127413603 @default.
• W1981724301 hasConceptScore W1981724301C142724271 @default.
• W1981724301 hasConceptScore W1981724301C149892131 @default.
• W1981724301 hasConceptScore W1981724301C170493617 @default.
• W1981724301 hasConceptScore W1981724301C197934379 @default.

• next